Page last updated: 2024-08-26

deoxypyridinoline and cabergoline

deoxypyridinoline has been researched along with cabergoline in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arslan, MS; Cakal, E; Caliskan, M; Demirci, T; Karakose, M; Ozbek, M; Ozdemir, S; Sahin, M; Topaloglu, O; Tutal, E; Ucan, B	1

Other Studies

1 other study(ies) available for deoxypyridinoline and cabergoline

Article	Year
SERUM LEVELS OF FIBROBLAST GROWTH FACTOR-23, OSTEOPROTEGERIN, AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND IN PATIENTS WITH PROLACTINOMA. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017, Volume: 23, Issue:3 Topics: Adult; Amino Acids; Antineoplastic Agents; Biomarkers, Tumor; Bone Density; Cabergoline; Cross-Sectional Studies; Ergolines; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Middle Aged; Osteocalcin; Osteoprotegerin; Pituitary Neoplasms; Prolactinoma; Prospective Studies; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Vitamin D	2017

Article

Year

SERUM LEVELS OF FIBROBLAST GROWTH FACTOR-23, OSTEOPROTEGERIN, AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND IN PATIENTS WITH PROLACTINOMA.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017, Volume: 23, Issue:3

Topics: Adult; Amino Acids; Antineoplastic Agents; Biomarkers, Tumor; Bone Density; Cabergoline; Cross-Sectional Studies; Ergolines; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Middle Aged; Osteocalcin; Osteoprotegerin; Pituitary Neoplasms; Prolactinoma; Prospective Studies; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Vitamin D

2017